Madrigal Pharmaceuticals (MDGL) Inventory Average (2024 - 2026)

Madrigal Pharmaceuticals (MDGL) has 3 years of Inventory Average data on file, last reported at $93.5 million in Q1 2026.

• On a quarterly basis, Inventory Average rose 109.29% year-over-year to $93.5 million in Q1 2026; TTM through Mar 2026 was $93.5 million, a 109.29% increase from a year earlier, with the FY2025 full-year figure at $54.5 million, changed N/A from the prior year.
• Inventory Average for Q1 2026 stood at $93.5 million, up from $72.1 million in the prior quarter.
• Over the last five years, Inventory Average for MDGL reached as high as $93.5 million in Q1 2026 and fell as low as $4.0 million in Q2 2024.
• Historically, Inventory Average has averaged $46.2 million across 3 years, with a median of $52.0 million in 2025.
• Across the five-year window, Inventory Average soared 1398.08% in 2025 and jumped 109.29% in 2026, its largest moves.
• Year by year, Inventory Average stood at $21.4 million in 2024, then surged by 236.95% to $72.1 million in 2025, then gained by 29.66% to $93.5 million in 2026.
• Per Business Quant data, the three most recent Inventory Average figures were $93.5 million in Q1 2026, $72.1 million in Q4 2025, and $66.4 million in Q3 2025.